share_log

HC Wainwright & Co. Reiterates Buy on AcelRx Pharmaceuticals, Maintains $5 Price Target

HC Wainwright & Co. Reiterates Buy on AcelRx Pharmaceuticals, Maintains $5 Price Target

HC Wainwright & Co.重申买入AcelRx Pharmicals,维持5美元的目标价
Benzinga ·  2023/12/07 06:45

HC Wainwright & Co. analyst Ed Arce reiterates AcelRx Pharmaceuticals (NASDAQ:ACRX) with a Buy and maintains $5 price target.

HC Wainwright & Co. 分析师埃德·阿尔塞重申了AcelrX Pharmicals(纳斯达克股票代码:ACRX)的买入并维持5美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发